Biopharma Facility Design Execution & Design Aspects - Austin Lock

Embed Size (px)

Citation preview

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    1/21

    Biopharma Facility Design Execution & Design AspectsAustin Lock

    BioPharma India Convention

    December 2010

    V20.3

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    2/21

    Agenda Biopharma Facility Design Execution & Design Approaches

    1. Facility Statement of Requirements (Design Brief)

    2. Facility Design Aspects3. Advances / Trends in Facility Design

    4. Summary

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    3/21

    1. Facility Statement of Requirements (Design Brief)

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    4/21

    Facility

    Statement ofRequirements(Design Brief)Specific

    BusinessRequirements

    Processes &Production

    Business CaseProject Drivers Facility

    Integrationinto Site

    Operations

    1.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    5/21

    Business Case, Project Drivers, Project Definition

    Before SOR Approval, the need to understand and define

    the reasons for a project / investment is essential

    Business Case & Objectives:

    Debottleneck / Capacity Increase / GMP / New Product /Cost of Goods

    Project Drivers:

    Cost Driven / Schedule Driven / Phasing of CapitalInvestment

    1.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    6/21

    Type of Facility: Production (Bulk, formulation & filling), packaging,R&D, Teaching

    Scale of Production: Clinical Trials / Market Entry / Production

    Proposed Markets and Regulatory Framework: National / Regional / Global

    WHO / CDSCO/ EU / FDA Specific Organisation Requirements:

    Attract Clients

    Attract & Retain Staff

    Centre of Excellence

    Low Cost of Production

    Flexibility or Not!

    Corporate Image e.g. green credentials Future requirements define what is to be designed for

    Specific Business Requirements1.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    7/21

    Processes & Production Drive the Facility Design

    Identify scope: single or multiproduct (campaign based / concurrent based)

    Identification of Type of Products - Impact facility design

    Expression systems & associated technology (Cell Culture, Microbial, Yeast, Viruses)

    Biosafety Level

    Scale of Operation (MABs cf. Viral Vectors)

    Requirement for viral segregation

    Identification of the Processes, Unit Operations, and associated Technologies

    Identification of critical process parameters and quality attributes Definition of Open and Closed Operations: Impact on Area Classifications

    Definition of all Process Support Operations: Material Prep, Washing, IPC etc

    The Processes and Production1.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    8/21

    Working shift pattern

    Level of automation

    Key Operational Philosophies (which impact layout andprocess design):

    CIP Philosophy

    Storage Philosophy Waste Handling

    Logistics Handling

    Maintenance Access & ergonomics

    Operations1.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    9/21

    Facility Integration into Site1.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    10/21

    FacilityStatement of

    Requirements(Design Brief)Specific

    BusinessRequirements

    Processes &Production

    Business CaseProject Drivers

    ProjectDefinition

    FacilityIntegration

    into Site

    Operations

    1.

    Initiated at the start of

    Feasibility / Concept

    Approved for the start of Basic

    Design Important to maintain

    consistency with SOR

    throughout Design Phases

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    11/21

    2. Facility Design Aspects

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    12/21

    Process Design2.

    Culture InoculationInoculation

    100L Primary Ferm.

    800L Secondary Ferm.

    Fermentation / ExtractionFermentation / Extraction

    800L Production Ferm.

    2500L Harvest Vessel

    3000L FlocculationVessel

    Centrifuge

    1200L CentrifugeReceiving Vessel

    HA Chromatography

    X2

    X6X2

    X2

    X2

    X1

    X2

    X2

    Be aware of over design!

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    13/21

    Segregation & Flow Concepts

    Identify the Segregation Concepts:

    Physical, procedural, environmental, and

    chronological (time)

    Primary Segregation addresses directenvironmental contamination threat (e.g.

    use of closed processing, segregation

    between different products or lots)

    Secondary Segregation - addressmanagement of the facility rather than

    intrinsic product protection (e.g. number

    of corridors, clean to dirty flow)

    Identify the Flow Philosophies:

    Personnel (Gowning Philosophy)

    Materials (Handling Philosophy)

    1 CORRIDOR

    2 CORRIDORS

    3 CORRIDORS

    2.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    14/21

    Vertical Concepts2.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    15/21

    Layout Development Process

    Operating

    Definitions

    Adjacency Diagrams

    Equipment Building Blocks

    Accommodation Schedule

    Segregation

    Concepts, Personnel

    / Material Handling

    Philosophies

    Flows,

    Constructability

    Fire Safety

    Concept

    Layouts, HVACDesign &

    Environmental

    Classification

    Facility

    Layout

    Process

    Definition

    2.

    HVAC Design &

    Environmental

    Classification

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    16/21

    Building Architecture

    External Internal

    2.

    Blend

    Functional

    Image

    Labs

    Offices

    Finishes

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    17/21

    3. Advances / Trends in Biopharma Facility Design

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    18/21

    Use disposable technologies to reducecapital investment, support closed

    processingGreater use of closed processing,

    lower environmental classifications

    Increased use of modular constructiontechnologies:

    Skids / Superskids

    Construction Modules

    More sustainable design features

    Advances / Trends in Facility Design

    3.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    19/21

    4. Summary

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    20/21

    Essential to understand and define Business Case and Drivers

    Important to maintain consistency with SOR throughout Design Phases

    The Processes & Production Drive the Facility Design

    Recognise that projects may fail in early design stages through over

    design

    Building architecture can promote company image and create an

    enhanced working environment

    Disposables and modular technologies are becoming more common

    place, but recognise impact on the design process

    Summary

    4.

  • 8/6/2019 Biopharma Facility Design Execution & Design Aspects - Austin Lock

    21/21

    Consultants, Engineers & Architects to

    the Biopharma Industry

    Thank You

    PM GroupFF-1, Alpine Arch

    #19/3, Langford Road

    Bangalore 560 027

    India

    Tel: +91 8040624062

    E-mail: [email protected]